undamentalytics Newsletter
Sign in

West Pharmaceutical Services balance sheet

At the end of fiscal 2025, West Pharmaceutical Services had total assets of $4.27bn, total liabilities of $1.09bn and shareholders' equity of $3.18bn. It held $791m in cash against $203m of debt: net cash of $588m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Cash and equivalents8311092162230255275203236337439616763894854485791464
Receivables139126147175186179181201278288319385489507512553574748
Inventory129147152162177182181199194215236321378415435377444465
Total current assets3974374725576516596746427448941,0591,3741,7421,9201,9361,5381,9781,817
Goodwill114113112113114109105103108106108111110107109106110109
Total assets1,2711,2941,3991,5641,6701,6701,6951,7171,8631,9792,3412,7943,3143,6173,8303,6434,2704,061
Accounts payable686390103108103120122138130157213232215242239254249
Deferred revenue (current)————222222628514957425052—
Total current liabilities171170243262237253314241280284342503594519672550655644
Short-term debt1050332276920022442134000
Long-term debt37935829937937130822922619719625525320920773203203203
Total debt380358349412374336299229198197258256254209207203203203
Total liabilities6926697448357657136715995835837689399789329499611,0941,093
Shareholders' equity5796266557299069571,0241,1181,2801,3961,5731,8552,3352,6852,8812,6823,1762,968
Net debt (negative = net cash)297248258250144802526−38−141−181−360−509−685−647−282−588−261
Shares outstanding——67m69m70m71m72m73m74m74m74m74m74m74m74m72m72m70m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: WST vs XRAYNVST vs WSTALGN vs WSTCOO vs WST

More: Health Care Supplies stocks compared, Health Care sector, rankings of US companies

Figures from West Pharmaceutical Services's SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to West Pharmaceutical Services.